The endocannabinoid system (ECS) is ubiquitous in most human tissues, and involved in
the regulation of mental health. Consequently, its dysregulation is associated with …

Cannabis has been used to treat convulsions and other disorders since ancient times. In the
last few decades, preclinical animal studies and clinical investigations have established the …

The endocannabinoid system (ECS) is composed of the two canonical receptor subtypes;
type-1 cannabinoid (CB1R) and type 2 receptor (CB2R), endocannabinoids (eCBs) and …

Artemisia argyi is commonly used as a remedy for gynecological and respiratory disease in
traditional Chinese medicine. The essential oil is considered as the major active ingredients …

Several valuable biologically active molecules can be obtained through C–H activation
processes. However, the use of expensive and not readily accessible catalysts complicates …

Cannabis contains over 500 distinct compounds, which include cannabinoids, terpenoids,
and flavonoids. However, very few of these compounds have been studied for their …

Epilepsy is characterized by repeated spontaneous bursts of neuronal hyperactivity and
high synchronization in the central nervous system. It seriously affects the quality of life of …

Intranasal delivery systems have been proposed as alternative routes for drug delivery to the
brain, primarily for treating diseases that affect the central nervous system. β-Caryophyllene …

While benzodiazepines have been a mainstay of the pharmacotherapy of anxiety disorders,
their short-term efficacy and risk of abuse have driven the exploration of alternative treatment …

Neurological disorders are the foremost occurring diseases across the globe resulting in
progressive dysfunction, loss of neuronal structure ultimately cell death. Therefore, attention …